Organoids as Oracles for Precision Medicine in Rectal Cancer

Summary Two recent papers in Cell Stem Cell and Nature Medicine ( Yao et al. [2019] and Ganesh et al. [2019] ) demonstrate the successful use of rectal cancer patient-derived organoids to predict patient responses to neoadjuvant chemoradiation therapy, paving the way toward a new paradigm for precision medicine.